Edition:
United Kingdom

Obalon Therapeutics Inc (OBLN.OQ)

OBLN.OQ on NASDAQ Stock Exchange Global Market

7.74USD
15 Dec 2017
Change (% chg)

$-0.08 (-1.02%)
Prev Close
$7.82
Open
$7.74
Day's High
$7.74
Day's Low
$7.74
Volume
14,665
Avg. Vol
9,287
52-wk High
$13.18
52-wk Low
$7.14

Chart for

About

Obalon Therapeutics, Inc. is a United States-based commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide... (more)

Overall

Beta: --
Market Cap(Mil.): $169.25
Shares Outstanding(Mil.): 16.82
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.01 10.62
ROE: -- 16.85 14.20

BRIEF-Obalon Therapeutics Q3 loss per share $0.55

* Q3 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

03 Nov 2017

BRIEF-Obalon Therapeutics & Sono Bello announce agreement to offer novel weight loss treatment

* Obalon Therapeutics Inc and Sono Bello announce agreement to offer novel weight loss treatment in Sono Bello centers

02 Nov 2017

BRIEF-Obalon Therapeutics files for mixed shelf of up to $100 mln

* Says in addition, selling stockholder may offer and sell up to 150,000 shares of co's common stock Source text: http://bit.ly/2z5bZGj Further company coverage:

01 Nov 2017

BRIEF-Obalon Q2 loss per share $0.46

* Q2 earnings per share view $-0.44 -- Thomson Reuters I/B/E/S

02 Aug 2017

Earnings vs. Estimates